Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 215110

MAVYRET (GLECAPREVIR; PIBRENTASVIR)
50MG;20MG/PACKET
Marketing Status: Prescription
Active Ingredient: GLECAPREVIR; PIBRENTASVIR
Proprietary Name: MAVYRET
Dosage Form; Route of Administration: PELLETS; ORAL
Strength: 50MG;20MG/PACKET
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: 
Application Number: N215110
Product Number: 001
Approval Date: Jun 10, 2021
Applicant Holder Full Name: ABBVIE INC
Marketing Status:  Prescription
Patent and Exclusivity Information

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English